Epilepsy is a disease which affects the quality of lives for many sufferers, hitting them with unexpected seizures and causing some degree of uncertainty as sufferers carry out their normal daily activities (find out more about what Epilepsy is here). There are many different forms of Epilepsy, but mainly grouped into Focal Seizures and Generalized Seizures. Given that this disease affects more than 50 million people worldwide, a cure is what many are hoping for.
Epilepsy news 24 August 2017 – the fight against Epilepsy
- Launch Of A New Drug By Eisai Pharmaceuticals, Fycompa To Fight Epilepsy
Eisai Pharmaceuticals has launched a new drug, Fycompa to fight against Epilepsy. This drug has been approved in more than 55 countries worldwide, and is designed as an adjunctive therapy (additional to the prescribed drugs). However, things which are not touched on in the article are the specific results or outcomes for patients taking the drug. At CuraHOPE, we hope to cover more in depth behind new drugs in the market to determine their efficacy and effectiveness.
- State Of Mexico Buys Medical Marijuana For Citizens
One Cannabis company, Medical Marijuana Inc received government import permits for bringing in Marijuana to treat patients suffering from rare forms of Epilepsy that have been claimed to be more effectively treated by CBD Oils (Cannabidol Oils). However, the clinical trials carried out in just 29 patients though statistically significant, feels a bit too stretched to determine a proper relationship. We feel that there should be higher accountability.
Sadly, there is still a lot we do not know about incurable diseases and their treatment methods. The relationships between pharmaceutical companies with hospitals and hospitals with doctors are very complex. At CuraHOPE, we hope to make the relationships a bit more transparent, and the industry a lot more considerate of patients.